Topical Testosterone Supplementation for the Treatment of Male Hypogonadism

被引:0
作者
Katrina A. Abadilla
Adrian S. Dobs
机构
[1] Johns Hopkins University/Sinai Hospital Program in Internal Medicine,Division of Endocrinology and Metabolism
[2] Johns Hopkins University,undefined
来源
Drugs | 2012年 / 72卷
关键词
Bone Mineral Density; Testosterone; Serum Testosterone; Testosterone Replacement Therapy; Testosterone Undecanoate;
D O I
暂无
中图分类号
学科分类号
摘要
Age-related hormonal decline is gradual and less recognized in men than in women. Symptoms are oftentimes ignored and non-specific. Fatigue, lack of concentration, mood swings, decreased sexual desire, erectile dysfunction, infertility, hair loss, reduced muscle and bone mass, and weight gain are a few of the symptoms of male hypogonadism. This disorder is linked to reduction in quality of life, and poorer health outcomes as it may increase the risk for cardiovascular disease, diabetes mellitus, metabolic syndrome, Alzheimer’s disease and premature death. Different modalities of testosterone replacement therapy have evolved over 70 years, and sales continue to grow. Each preparation is differentiated by route of delivery, ease of use, cost and pharmacokinetics.
引用
收藏
页码:1591 / 1603
页数:12
相关论文
共 149 条
[1]  
Diver M.J.(2003)Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men Clin Endocrinol 58 710-7
[2]  
Imtiaz K.E.(2003)Variation in levels of serum inhibin b, testosterone, estradiol, luteinizing hormone, follicle-stimulating hormone, and sex hormone-binding globulin in monthly samples from healthy men during a 17-month period: possible effects of seasons J Clin Endocrinol Metab 88 932-7
[3]  
Ahmad A.M.(2001)Longitudinal effects of aging on serum total and free testosterone levels in healthy men: Baltimore longitudinal study of aging J Clin Endocrinol Metab 86 724-31
[4]  
Andersson A.M.(1997)Declining gonadal function in elderly men Baillieres Clin Endocrinol Metab 11 289-309
[5]  
Carlsen E.(2001)Effects of age on testicular function and con-sequences of testosterone treatment J Clin Endocrinol Metab 86 2369-72
[6]  
Petersen J.H.(2007)The latest options and future agents for treating male hypogonadism Expert Opin Pharmacother 8 2991-3008
[7]  
Harman S.M.(2008)Current and future testosterone delivery systems for treatment of the hypogonadal male Expert Opin Durg Deliv 5 471-81
[8]  
Metter E.J.(2004)Testosterone replacement therapy: current trends and future directions Hum Reprod Update 10 409-19
[9]  
Tobin J.D.(2002)American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult patients: 2002 update Endocr Pract 8 440-56
[10]  
Kaufman J.M.(2009)The benefits and risks of testosterone replacement therapy: a review Ther Clin Risk Manag 5 427-48